# MapLight Therapeutics Raises $372.5 Million Series D for CNS Drug Discovery

> financing · REPORTED · 2025-07-29

MapLight Therapeutics announced a $372.5 million Series D financing round in July 2025, reflecting growing investor enthusiasm for neurology-focused biotechs and providing capital to advance its CNS drug discovery platform.

- Company: MapLight Therapeutics
- Sector: neurotech
- Primary source: https://www.ropesgray.com/en/insights/alerts/2026/03/from-volatility-to-vitality-how-2025-reset-the-life-sciences-market-and-whats-next-for-2026

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.